These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8117520)

  • 1. [The pharmacological therapy of intrahepatic cholestasis].
    Coltorti M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():41S-47S. PubMed ID: 8117520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A meta-analysis of therapeutic trials with ademetionine in the treatment of intrahepatic cholestasis].
    Frezza M
    Ann Ital Med Int; 1993 Oct; 8 Suppl():48S-51S. PubMed ID: 8117521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ademetionine: the state of the art and future prospects].
    Almasio P; Pagliaro L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():52S-55S. PubMed ID: 8117523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of the studies on the clinical use of S-adenosylmethionine (SAMe) for the symptomatic treatment of intrahepatic cholestasis.
    Coltorti M; Bortolini M; Di Padova C
    Methods Find Exp Clin Pharmacol; 1990; 12(1):69-78. PubMed ID: 2179653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of ursodeoxycholic acid on the liver plasma membrane fluidity, hepatic glutathione concentration, hepatic estrogen receptors and progesterone receptors in pregnant rats with ethinylestradiol and progesterone induced intrahepatic cholestasis].
    Shi QY; Kong BH; Ma KD; Zhang XL; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 2003 Nov; 38(11):680-2. PubMed ID: 14728856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of the obstetrical risk in pregnant women with intrahepatic cholestasis treated with S-adenosyl-L-methionine].
    Lafuenti G; Plotti G; Nicolanti G; Gaglione R; Tibollo FG; Mancuso S
    Recenti Prog Med; 1988 Oct; 79(10):420-3. PubMed ID: 3247511
    [No Abstract]   [Full Text] [Related]  

  • 8. S-Adenosylmethionine protects against cyclosporin A-induced alterations in rat liver plasma membrane fluidity and functions.
    Galán AI; Muñoz ME; Jiménez R
    J Pharmacol Exp Ther; 1999 Aug; 290(2):774-81. PubMed ID: 10411591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy.
    Binder T; Salaj P; Zima T; Vítek L
    J Perinat Med; 2006; 34(5):383-91. PubMed ID: 16965225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intrahepatic cholestasis in chronic liver diseases].
    Golovanova EV; Petrakov AV; Noskova KK
    Eksp Klin Gastroenterol; 2011; (2):58-67. PubMed ID: 21560642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis.
    Almasio P; Bortolini M; Pagliaro L; Coltorti M
    Drugs; 1990; 40 Suppl 3():111-23. PubMed ID: 2081476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign recurrent intrahepatic cholestasis: failure of S-adenosylmethionine therapy.
    Ghent CN
    Hepatology; 1990 Aug; 12(2):367-8. PubMed ID: 2391074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical trial of heptral in patients with chronic diffuse liver disease with intrahepatic cholestasis syndrome].
    Podymova SD; Nadinskaia MIu
    Klin Med (Mosk); 1998; 76(10):45-8. PubMed ID: 9865018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign recurrent intrahepatic cholestasis: treatment with S-adenosylmethionine.
    Everson GT; Ahnen D; Harper PC; Krawitt EL
    Gastroenterology; 1989 May; 96(5 Pt 1):1354-7. PubMed ID: 2703120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A trial of using Geptral in patients with chronic liver diseases].
    Gorbakov VV; Kalinin AV; Ermolin SN
    Voen Med Zh; 1996 Dec; 317(12):29-31. PubMed ID: 9163214
    [No Abstract]   [Full Text] [Related]  

  • 16. Progressive intrahepatic cholestasis: mechanisms, diagnosis and therapy.
    Shneider BL
    Pediatr Transplant; 2004 Dec; 8(6):609-12. PubMed ID: 15598335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of heptral in the complex treatment of pregnant women with cholestatic liver disease].
    Lineva OI; Osadchenko EIu; Nesterenko SA
    Eksp Klin Gastroenterol; 2002; (3):33-8, 119. PubMed ID: 12353385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adenosyl-methionine in alcoholic liver disease and intrahepatic cholestasis.
    Testino G; Leone S; Fagoonee S; Pellicano R
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):187-189. PubMed ID: 29521488
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and therapy of intrahepatic cholestasis of pregnancy.
    Paus TC; Schneider G; Van De Vondel P; Sauerbruch T; Reichel C
    Z Gastroenterol; 2004 Jul; 42(7):623-8. PubMed ID: 15248112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of bezafibrate on dyslipidemia with cholestasis in children with familial intrahepatic cholestasis-1 deficiency manifesting progressive familial intrahepatic cholestasis.
    Nagasaka H; Yorifuji T; Hirano K; Ota A; Toyama-Nakagawa Y; Takatani T; Tsukahara H; Kobayashi K; Takayanagi M; Inomata Y; Uemoto S; Miida T
    Metabolism; 2009 Jan; 58(1):48-54. PubMed ID: 19059530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.